Propallylonal

Propallylonal

File:Propallylonal.svg

Chemical structure of Propallylonal

Propallylonal is a barbiturate derivative that has been used as a sedative and hypnotic agent. It is known for its ability to depress the central nervous system, leading to effects such as sedation, anxiolysis, and hypnosis.

Chemical Properties

Propallylonal is chemically classified as a barbiturate, which is a class of drugs derived from barbituric acid. The chemical structure of propallylonal includes a pyrimidine ring, which is characteristic of barbiturates. The presence of an allyl group in its structure distinguishes it from other barbiturates.

Mechanism of Action

Propallylonal, like other barbiturates, acts by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter in the brain. It binds to the GABA_A receptor, increasing the duration of chloride ion channel opening, which leads to hyperpolarization of the neuron and a decrease in neuronal excitability.

Clinical Uses

Historically, propallylonal was used for its sedative and hypnotic properties. It was prescribed to patients suffering from insomnia and anxiety disorders. However, due to the development of safer alternatives, its use has declined.

Side Effects

The use of propallylonal can lead to several side effects, including drowsiness, dizziness, and respiratory depression. In higher doses, it can cause coma and even death.

Pharmacokinetics

Propallylonal is metabolized in the liver and excreted by the kidneys. Its half-life can vary depending on the individual's metabolic rate and liver function.

Historical Context

Barbiturates like propallylonal were first introduced in the early 20th century and were widely used until the development of benzodiazepines and other safer sedative-hypnotics. The decline in their use is attributed to their narrow therapeutic index and high potential for abuse and dependence.

Related Pages

• Barbiturate
• Sedative
• Hypnotic
• GABA_A receptor
• Insomnia